cdr

Hot Keywords
Drug Resistance Mechanisms Epigenetic Resistance in Cancer Therapy Biomarkers Pharmacogenetics of Cancer Liquid Biopsy Targeted Cancer Therapy Non-coding RNAs Kinase Inhibitors ABC Transporters

Top
Partners

Cooperating conferences

EORTC-PAMM Meeting

Time and Venue: 21-22 April 2021 | Virtual Event

About: EORTC is an independent, non-profit cancer research organization, our mission is to coordinate and conduct international translational and clinical research to improve the standard of cancer treatment for patients. The aim ultimately to increase people’s survival and quality of life by testing new therapeutic strategies based on existing drugs, surgery and radiotherapy. We also help develop new drugs and approaches in partnership with the pharmaceutical industry and in patients’ best interests.
The EORTC-PAMM groups appreciates the kind willingness of the journal Cancer Drug Resistance to sponsor two awards for the best presentation on each day of the meeting.

Website: https://www.eortc.org/event/eortc-pamm-meeting/

8th Immunotherapy of Cancer Conference (ITOC8)

Time and Venue: 8-9 October 2021 | Virtual Conference

About: The 8th Immunotherapy of Cancer Conference (ITOC8) is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.
ITOC8 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery

Website: https://www.itoc-conference.eu/

Previous conferences

7th Immunotherapy of Cancer Conference (ITOC7)

Time and Venue: 2-3 October 2020 | Virtual Conference

About: The 7th Immunotherapy of Cancer Conference (ITOC7) to be held in Munich, Germany from October 2-3, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation to address its unique challenges.
ITOC7 is organized by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.

Website: https://www.itoc-conference.eu/

Copyright © 2021 OAE Publishing Inc. All Rights Reserved.